{
    "applicationNumber": "BR 11 2022 021450-2",
    "filingDate": "23/04/2021",
    "grantDate": null,
    "title": "O CD19 OU FRAGMENTO DE LIGA\u00c7\u00c3O, M\u00c9TODO DE TRATAMENTO DE UM C\u00c2NCER, COMPOSI\u00c7\u00c3O FARMAC\u00caUTICA, \u00c1CIDO NUCLEICO, VETOR, E, C\u00c9LULA ISOLADA",
    "nationalPhaseDate": [
        "21/10/2022"
    ],
    "internationalApplication": {
        "pctNumber": "PCT US2021/028880",
        "pctDate": "23/04/2021",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "63/015,385",
            "priorityDate": "24/04/2020"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2704"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2712"
        }
    ],
    "inventors": [
        "DANIEL TAVARES",
        "BIANKA PRINZ",
        "JAMES GEOGHEGAN"
    ],
    "holders": [
        81438
    ],
    "ipcCodes": [
        "A61K 39/395",
        "A61P 35/02",
        "C07K 16/28"
    ]
}